Crinetics Pharmaceuticals Inc. (CRNX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crinetics Pharmaceuticals...

    NASDAQ: CRNX · Real-Time Price · USD
    36.50
    1.36 (3.87%)
    At close: Sep 09, 2025, 3:59 PM
    37.00
    1.37%
    Pre-market: Sep 10, 2025, 04:41 AM EDT

    Crinetics Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 264.55M 54.9M 32.67M 200.69M
    Short-Term Investments
    		 1.09B 503.66M 301.75M 133.01M
    Long-Term Investments
    		 800K 1.77M 1.97M 1.01M
    Other Long-Term Assets
    		 2.83M 2M 37K 568K
    Receivables
    		 8.47M 9.35M 2.42M 2.03M
    Inventory
    		 n/a n/a n/a -2.03M
    Other Current Assets
    		 1.71M 1.58M 4.83M 2.03M
    Total Current Assets
    		 1.38B 574.15M 345.18M 344.72M
    Property-Plant & Equipment
    		 55.58M 57.43M 4.99M 4.72M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 59.2M 61.2M 6.99M 6.29M
    Total Assets
    		 1.43B 635.35M 352.18M 351.01M
    Account Payables
    		 5.85M 6.55M 6.88M 3.42M
    Deferred Revenue
    		 2.18M 2.06M 2.24M -939K
    Short-Term Debt
    		 7.15M 4.17M 1.05M 939K
    Other Current Liabilities
    		 -7.14M 12.47M 7.42M n/a
    Total Current Liabilities
    		 59.68M 43.94M 27.72M 15.99M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 829K n/a 6.1M 2K
    Total Long-Term Liabilities
    		 50.1M 52.3M 8.13M 3.08M
    Total Liabilities
    		 109.79M 96.25M 35.85M 19.07M
    Total Debt
    		 51.72M 51.73M 3.08M 3.07M
    Common Stock
    		 2.28B 1.19B 759.43M 607.58M
    Retained Earnings
    		 -952.11M -653.7M -439.17M -275.25M
    Comprehensive Income
    		 963K 977K -3.93M -382K
    Shareholders Equity
    		 1.32B 539.11M 316.33M 331.94M
    Total Investments
    		 1.09B 505.43M 301.75M 134.02M

    Add to Watchlist